Company: MDCXW
Filing Date: 2025-09-11
Form Type: DRS
Source: 0001062993-25-015568
Chunk: 151

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-11
Form: DRS
Chunk 151
---
9  | Pending | LifeArc   |
| Mexico        | Composition for treating one or more estrogen related diseases |  2020011341 | 4/26/2018 | 4/25/2019  |            |           | 4/25/2039  | Pending | LifeArc   |

<div align='center'>99</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

| Country       
 Name          | Title                                     | Application 
         No. | Priority 
 Date     | Filed      
 Date       |     Patent 
        No. | Issue     
 Date      | Projected  
 Expiration 
 Date       | Status  | Assignee      
 (s)           |
| United States | Reconstitutable teverelix-TFA composition |  17/254,859 | 7/5/2018 | 12/22/2020 | 11,633,453 | 4/5/2023  | 7/2/2039   | Issued  | Antev Limited |
| United States | Reconstitutable teverelix-TFA composition |  18/122,991 | 7/5/2018 | 3/17/2023  |            |           | 7/2/2039   | Pending | Antev Limited |
| Europe        | Reconstitutable teverelix-TFA composition |  18181931.9 | 7/5/2018 | 7/5/2018   |    3590524 | 11/4/2020 | 7/2/2039   | Issued  | Antev Limited |
| Europe        | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
| Germany       | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |